SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
The Capsule
The Capsule
Page 5 of 9
Newsletters
The COVID pandemic pits competition against collaboration
By
Sy Mukherjee
February 11, 2021
Newsletters
Would you get a COVID vaccine that’s less effective than other ones?
By
Sy Mukherjee
February 4, 2021
Newsletters
President Biden’s health care sprint begins
By
Sy Mukherjee
January 28, 2021
Newsletters
A new president takes on one of the biggest vaccine challenges in history
By
Sy Mukherjee
January 21, 2021
Newsletters
Pfizer or Moderna? A COVID vaccine distribution dilemma
By
Sy Mukherjee
January 14, 2021
Newsletters
COVID vaccine distribution gets off to a shaky start
By
Sy Mukherjee
January 7, 2021
Newsletters
How a molecule gets to the masses
By
Sy Mukherjee
December 17, 2020
Newsletters
What happens next: 10 non-COVID health care predictions for 2021
By
Sy Mukherjee
December 10, 2020
Newsletters
What leaders can learn from a global pandemic
By
Sy Mukherjee
December 3, 2020
Newsletters
The sad science of pandemic grief
By
Sy Mukherjee
November 19, 2020
Newsletters
The scientific link between Pfizer’s and Moderna’s COVID vaccines
By
Sy Mukherjee
November 12, 2020
Newsletters
The election might be top of mind but 234,000 people are dead, with many in swing states
By
Sy Mukherjee
November 5, 2020
Newsletters
Two tales of innovation from CVS and Pfizer
By
Sy Mukherjee
October 29, 2020
Newsletters
Gilead just got the first FDA coronavirus treatment approval, but there are still problems
By
Sy Mukherjee
October 22, 2020
Newsletters
How chief health officers could help campuses navigate COVID
By
Sy Mukherjee
October 15, 2020
Most Popular
Success
Multimillion-dollar restaurant CEO used to splurge on Range Rovers and McLarens—but he’s reining it in now because...
By
Emma Burleigh
AI
'Godfather of AI' says the technology will create massive unemployment and send profits soaring — 'that is the...
By
Jason Ma
Tech
‘Yes, you read that correctly’: Tesla pay committee pitches $1 trillion pact to keep Elon Musk as CEO for long term
By
Nick Lichtenberg